These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 884934)

  • 1. Effect of warfarin on the metabolism of phylloquinone (vitamin K1):dose-response relationships in man.
    Shearer MJ; McBurney A; Breckenridge AM; Barkhan P
    Clin Sci Mol Med; 1977 Jun; 52(6):621-30. PubMed ID: 884934
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose - response relationship between warfarin and the metabolism of phylloquinone (vitamin K1) in man.
    Shearer MJ; McBurney A; Breckenridge A; Barkhan P
    Int J Vitam Nutr Res; 1976; 46(2):215-9. PubMed ID: 1032634
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of vitamin K1 (phylloquinone) in man.
    Barkhan P; Shearer MJ
    Proc R Soc Med; 1977 Feb; 70(2):93-6. PubMed ID: 859820
    [No Abstract]   [Full Text] [Related]  

  • 4. Enantiomers of warfarin and vitamin K1 metabolism.
    Choonara IA; Haynes BP; Cholerton S; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1986 Dec; 22(6):729-32. PubMed ID: 3567019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the effects of warfarin and brodifacoum on the relationship between vitamin K1 metabolism and clotting factor activity in warfarin-susceptible and warfarin-resistant rats.
    Leck JB; Park BK
    Biochem Pharmacol; 1981 Jan; 30(2):123-8. PubMed ID: 7236301
    [No Abstract]   [Full Text] [Related]  

  • 6. The dose-dependent effect of warfarin on vitamin K1 metabolism and clotting factor synthesis in the rabbit.
    Park BK; Leck JB; Breckenridge AM
    Biochem Pharmacol; 1980 Jun; 29(11):1601-2. PubMed ID: 7396990
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man.
    Shearer MJ; McBurney A; Barkhan P
    Vitam Horm; 1974; 32():513-42. PubMed ID: 4617407
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of warfarin anticoagulation on vitamin-K 1 metabolism in man.
    Shearer MJ; McBurney A; Barkhan P
    Br J Haematol; 1973 Apr; 24(4):471-9. PubMed ID: 4715142
    [No Abstract]   [Full Text] [Related]  

  • 9. A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonists.
    Ross PJ; Shearer MJ; Diplock AT; Schey SA
    Br J Haematol; 1991 Feb; 77(2):195-200. PubMed ID: 2004021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin and the inhibition of vitamin K activity by an oxide metabolite.
    Bell RG; Matschiner JT
    Nature; 1972 May; 237(5349):32-3. PubMed ID: 4555434
    [No Abstract]   [Full Text] [Related]  

  • 11. Variation in the response of human beings to vitamin K1.
    Zieve PD; Solomon HM
    J Lab Clin Med; 1969 Jan; 73(1):103-10. PubMed ID: 5762156
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in the urinary metabolites of phylloquinone (vitamin K1) in man following therapeutic anticoagulation with warfarin.
    McBurney A; Shearer MJ; Barkhan P
    Biochem Pharmacol; 1978 Feb; 27(3):273-8. PubMed ID: 619911
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of warfarin resistance. Warfarin and the metabolism of vitamin K 1 .
    Bell RG; Caldwell PT
    Biochemistry; 1973 Apr; 12(9):1759-62. PubMed ID: 4699235
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of warfarin and the chloro analog of vitamin K 1 on phylloquinone metabolism.
    Thierry MJ; Suttie JW
    Arch Biochem Biophys; 1971 Dec; 147(2):430-5. PubMed ID: 5136094
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of phylloquinone from an intravenous lipid emulsion.
    Camilo ME; Jatoi A; O'Brien M; Davidson K; Sokoll L; Sadowski JA; Mason JB
    Am J Clin Nutr; 1998 Apr; 67(4):716-21. PubMed ID: 9537619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
    Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients.
    Choonara IA; Scott AK; Haynes BP; Cholerton S; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1985 Dec; 20(6):643-8. PubMed ID: 4091996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1.
    Bjornsson TD; Meffin PJ; Swezey SE; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):322-6. PubMed ID: 480184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.
    Nee R; Doppenschmidt D; Donovan DJ; Andrews TC
    Am J Cardiol; 1999 Jan; 83(2):286-8, A6-7. PubMed ID: 10073841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo metabolism of vitamin K: in relation to the conversion of vitamin K1 to MK-4].
    Okano T; Nakagawa K; Kamao M
    Clin Calcium; 2009 Dec; 19(12):1779-87. PubMed ID: 19949269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.